There's an old saying in sales: people buy from people they like. That's true — but it doesn't go far enough. The deeper truth, the one neuroscience has been quietly confirming for decades, is that people buy from people they trust. And trust isn't a feeling you can manufacture with a warm smile and a firm handshake. It's a chemical event in the brain.
In this conversation from the Science of Sales podcast, we unpacked the brain chemistry behind authentic connection — why some sales conversations produce immediate, lasting trust while others leave both parties feeling like something was off. What we found explains a lot about the patterns you've probably noticed in your own pipeline without ever having the language to describe them.
The Old Adage, Rewritten
"People buy from people they like" has been the foundational creed of relationship selling for generations. It's not wrong. Likeability matters. But it's a surface-level observation that points to something much more specific happening underneath.
When you reframe the adage through neuroscience, it becomes: people buy from people whose presence reduces the threat response in their brain. That shift changes everything about how you approach a sales conversation. Likeability is an output. What you're actually engineering is a neurochemical state.
The brain doesn't decide to trust you because your pitch was compelling. It decides to trust you because the chemical signals it receives from the interaction tell it that you're safe, that you understand its world, and that you're not there to take something from it. Get those signals right, and the conversation changes completely.
Two Chemicals Running Your Sales Calls
Every sales conversation is shaped, in large part, by two neurochemicals: cortisol and oxytocin. They work in opposition. One closes people down; the other opens them up. Understanding which one you're triggering — and why — is the foundation of trust-based selling.
Most sellers, without realizing it, spend the opening minutes of a conversation activating the wrong one.
Cortisol: The Conversation Killer
Cortisol is the brain's primary stress hormone. Its job is to keep you alive in threatening situations — it sharpens your focus on the threat, suppresses non-essential functions, and prepares the body to fight or flee. In a sales context, it's the reason a prospect becomes closed off, short-answered, or defensive the moment they sense they're being sold to.
What triggers cortisol in a sales interaction? Leading with your product. Jumping to features and benefits before the prospect feels heard. Creating urgency before you've established relevance. Asking leading questions designed to funnel a prospect toward your conclusion rather than genuinely understanding theirs. All of these moves signal — at a neurological level — that this conversation is about you, not them.
When cortisol is running the room, the rational, decision-making parts of the brain go quiet. The prospect's prefrontal cortex, where logic and evaluation live, takes a back seat to the amygdala's threat detection. You can present the most well-crafted value proposition in the world, and it won't land — because the brain isn't in a state to receive it.
Oxytocin: The Trust Molecule
Oxytocin does the opposite. It's the neurochemical most associated with bonding, empathy, and social connection. When it's present, people feel safe, engaged, and open. The threat-detection system quiets down, and the brain becomes receptive to information, stories, and ideas.
Oxytocin is released when someone feels genuinely understood. When a conversation makes a person feel seen — not just as a buyer, but as a human being with real problems, real pressures, and real stakes — their brain starts producing it. That's the chemical basis for what we usually call "rapport." But true connection goes deeper than rapport, and the distinction matters enormously in selling.
Trust Before Credibility, Not the Other Way Around
Here's where most sales training gets the sequence backwards. The traditional model tells you to establish credibility first: show your track record, prove your expertise, demonstrate your ROI. Then, once the prospect is impressed, you earn their trust.
The brain doesn't work that way.
Credibility is processed in the rational brain. But before the rational brain will engage with your credibility claims, the emotional brain needs to feel safe. If the prospect's threat response is active, the credibility data you're presenting never gets evaluated fairly. It gets filtered through a lens of skepticism and self-protection.
When you lead with trust — when you demonstrate that you understand the prospect's world before you start pitching your solutions — the emotional brain shifts states. Cortisol drops. Oxytocin rises. The prefrontal cortex comes back online. And now, when you make a credibility claim, the brain is actually able to hear it, weigh it, and believe it.
This is why the sellers who consistently close the most complex deals aren't the ones with the strongest product decks. They're the ones who make prospects feel most understood in the first 10 minutes of a conversation.
The Difference Between Rapport and Real Connection
"Building rapport" has become a catch-all phrase in sales training for a collection of surface-level behaviors: mirroring body language, finding common ground on sports or hobbies, being warm and personable. None of that is bad. But it doesn't reliably produce oxytocin, and it doesn't produce lasting trust.
Real connection requires something more specific: demonstrating that you understand the emotional context of the prospect's situation, not just the functional one. Most sellers understand the functional context. They know the prospect wants to increase revenue, reduce costs, or improve efficiency. But the prospect's boss is breathing down their neck. There's a board presentation in three weeks. The last vendor they trusted left them holding the bag. Their team is skeptical of another new initiative.
That's the emotional context. And when a seller shows up having done the work to understand it — when they name the pressures the prospect is carrying without being asked — the prospect's brain responds with a very different chemical cocktail than it does when someone leads with a slide deck.
The old adage says people buy from people they like. The upgrade says: people buy from people who make them feel understood before they've said a word about their product.
What This Means for Your Sales Conversations
The practical application of this science isn't complicated, but it does require a deliberate change in sequence. Before you go into any sales conversation, ask yourself three questions: What does this person's world actually look like right now? What pressures are they under that have nothing to do with my product? What would it mean for them personally — not just professionally — if this problem got solved?
Open the conversation with those answers, framed as observations and hypotheses, not as questions designed to funnel toward your close. "I imagine you're seeing X right now" is fundamentally different from "Are you experiencing challenges with X?" The first demonstrates understanding. The second signals an agenda.
When you demonstrate understanding first, you create the neurochemical conditions for credibility to land. The prospect's brain stops looking for the threat and starts looking for the solution. That's when your product story becomes genuinely persuasive — not because you pushed harder, but because the brain was ready to receive it.
The Bottom Line
Trust isn't a personality trait or a lucky byproduct of a good conversation. It's a neurochemical outcome that you can reliably engineer by understanding what the brain needs before it can say yes. Lead with understanding. Let credibility follow. Put trust before the pitch, and watch what happens to your close rates, your cycle times, and the depth of the relationships you build with the people on the other side of the table.
Worth exploring this further for your team? Start a conversation with us about what NeuroSelling looks like in your pipeline.
